Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 Infection

<p><br></p><p dir="ltr">The global pandemic of COVID-19 disease caused by infection with the SARS-CoV-2 coronavirus, has produced an urgent requirement and search for improved treatments while effective vaccines are developed. A strategy for improved drug therapy is...

Full description

Saved in:
Bibliographic Details
Main Author: Maryam S. Al-Motawa (9501818) (author)
Other Authors: Hafsa Abbas (9501821) (author), Patrick Wijten (2029159) (author), Alberto de la Fuente (360936) (author), Mingzhan Xue (3607649) (author), Naila Rabbani (291722) (author), Paul J. Thornalley (291723) (author)
Published: 2020
Subjects:
Biological sciences
Bioinformatics and computational biology
Microbiology
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
COVID-19
coronavirus
methylglyoxal
glyoxalase
doxorubicin
paclitaxel
proteomics
bioinformatics
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items